Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897988 · ClinicalTrials.gov registry record
DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT00897988 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00897988 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at the DNA in tumor tissue samples from patients with human papilloma virus-associated cancer of the oropharynx.
Interventions
- GENETIC gene expression analysis
- GENETIC protein expression analysis
- GENETIC mutation analysis
- GENETIC polymerase chain reaction
- GENETIC polyacrylamide gel electrophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897988
The ClinicalTrials.gov registry entry for NCT00897988 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00897988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897988 about?
NCT00897988 is a clinical study titled "DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx". RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at the DNA in tumor tissue samples from patients with human papill...
What is the current status of trial NCT00897988?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2006-04.
What interventions are being tested in trial NCT00897988?
The interventions under investigation include: gene expression analysis (GENETIC), protein expression analysis (GENETIC), mutation analysis (GENETIC), polymerase chain reaction (GENETIC), polyacrylamide gel electrophoresis (GENETIC).
Who is sponsoring clinical trial NCT00897988?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.